NEW YORK, Nov. 14 (GenomeWeb News) - DNAPrint Genomics and SeraCare Life Sciences' Genomics Collaborative division plan to identify genetic factors associated with how cancer patients respond to carboplatin/tamoxifen-based chemotherapy, DNAPrint said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.